Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Puglisi

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
ESMO Open|November 18, 2022
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic reviewV Di Lauro, G Barchiesi, F Martorana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2008
Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancerC Andreetta, C Puppin, A Minisini, et al.
Breast (Edinburgh, Scotland)|June 28, 2026
What are the determinants of type of breast surgery following neoadjuvant chemotherapy? An analysis of breast cancer patients among Italian SENONET centers: NEOIMPACT studyA De Luca, M I Amabile, M Tomatis, et al.
Future Oncology (London, England)|February 25, 2015
Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patientsG Mustacchi, F Puglisi, A M Molino, et al.
Breast (Edinburgh, Scotland)|February 27, 2010
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancerM Venturini, C Bighin, F Puglisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2019
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)T Bachelot, E Ciruelos, A Schneeweiss, et al.
International Journal of Obesity (2005)|May 26, 2011
The effects of weight loss due to gastric banding and lifestyle modification on red blood cell aggregation and deformability in severe obese subjectsP Capuano, G Catalano, G Garruti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancerF Puglisi, G G Cardellino, D Crivellari, et al.
Cancer Treatment Reviews|June 26, 2018
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtypeL Gerratana, D Basile, G Buono, et al.
Neurobiology of Disease|February 27, 2016
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout miceG Martella, G Madeo, M Maltese, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
ESMO Open|November 18, 2022
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic reviewV Di Lauro, G Barchiesi, F Martorana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2008
Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancerC Andreetta, C Puppin, A Minisini, et al.
Breast (Edinburgh, Scotland)|June 28, 2026
What are the determinants of type of breast surgery following neoadjuvant chemotherapy? An analysis of breast cancer patients among Italian SENONET centers: NEOIMPACT studyA De Luca, M I Amabile, M Tomatis, et al.
Future Oncology (London, England)|February 25, 2015
Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patientsG Mustacchi, F Puglisi, A M Molino, et al.
Breast (Edinburgh, Scotland)|February 27, 2010
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancerM Venturini, C Bighin, F Puglisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2019
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)T Bachelot, E Ciruelos, A Schneeweiss, et al.
International Journal of Obesity (2005)|May 26, 2011
The effects of weight loss due to gastric banding and lifestyle modification on red blood cell aggregation and deformability in severe obese subjectsP Capuano, G Catalano, G Garruti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancerF Puglisi, G G Cardellino, D Crivellari, et al.
Cancer Treatment Reviews|June 26, 2018
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtypeL Gerratana, D Basile, G Buono, et al.
Neurobiology of Disease|February 27, 2016
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout miceG Martella, G Madeo, M Maltese, et al.
Pageof 13